Compare Jubilant Pharmova with STRIDES PHARMA SCIENCE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT PHARMOVA vs STRIDES PHARMA SCIENCE - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    JUBILANT PHARMOVA STRIDES PHARMA SCIENCE JUBILANT PHARMOVA /
STRIDES PHARMA SCIENCE
 
P/E (TTM) x 14.0 20.7 67.6% View Chart
P/BV x 1.9 2.8 69.0% View Chart
Dividend Yield % 0.7 1.8 41.4%  

Financials

 JUBILANT PHARMOVA    STRIDES PHARMA SCIENCE
EQUITY SHARE DATA
    JUBILANT PHARMOVA
Mar-20
STRIDES PHARMA SCIENCE
Mar-20
JUBILANT PHARMOVA /
STRIDES PHARMA SCIENCE
5-Yr Chart
Click to enlarge
High Rs727547 132.8%   
Low Rs230271 84.9%   
Sales per share (Unadj.) Rs574.7332.8 172.7%  
Earnings per share (Unadj.) Rs56.415.4 366.5%  
Cash flow per share (Unadj.) Rs85.436.4 234.9%  
Dividends per share (Unadj.) Rs5.0014.00 35.7%  
Dividend yield (eoy) %1.03.4 30.5%  
Book value per share (Unadj.) Rs351.8281.5 125.0%  
Shares outstanding (eoy) m159.2889.57 177.8%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.81.2 67.7%   
Avg P/E ratio x8.526.6 31.9%  
P/CF ratio (eoy) x5.611.3 49.8%  
Price / Book Value ratio x1.41.5 93.6%  
Dividend payout %8.991.0 9.7%   
Avg Mkt Cap Rs m76,22036,648 208.0%   
No. of employees `000NANA-   
Total wages/salary Rs m21,2774,426 480.8%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m91,54429,811 307.1%  
Other income Rs m474667 71.1%   
Total revenues Rs m92,01830,478 301.9%   
Gross profit Rs m19,1244,325 442.1%  
Depreciation Rs m4,6191,878 246.0%   
Interest Rs m2,8741,557 184.6%   
Profit before tax Rs m12,1051,557 777.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,123179 1,743.5%   
Profit after tax Rs m8,9821,378 651.7%  
Gross profit margin %20.914.5 144.0%  
Effective tax rate %25.811.5 224.3%   
Net profit margin %9.84.6 212.2%  
BALANCE SHEET DATA
Current assets Rs m50,38323,721 212.4%   
Current liabilities Rs m26,19025,449 102.9%   
Net working cap to sales %26.4-5.8 -456.1%  
Current ratio x1.90.9 206.4%  
Inventory Days Days7154 4.2%  
Debtors Days Days52114 45.2%  
Net fixed assets Rs m72,72135,810 203.1%   
Share capital Rs m159896 17.8%   
"Free" reserves Rs m55,88024,321 229.8%   
Net worth Rs m56,03925,217 222.2%   
Long term debt Rs m37,3976,039 619.2%   
Total assets Rs m123,10459,532 206.8%  
Interest coverage x5.22.0 260.6%   
Debt to equity ratio x0.70.2 278.7%  
Sales to assets ratio x0.70.5 148.5%   
Return on assets %9.64.9 195.3%  
Return on equity %16.05.5 293.3%  
Return on capital %16.010.0 160.9%  
Exports to sales %048.2 0.0%   
Imports to sales %14.80-   
Exports (fob) Rs mNA14,364 0.0%   
Imports (cif) Rs m13,515NA-   
Fx inflow Rs m15,51516,020 96.8%   
Fx outflow Rs m13,515352 3,843.1%   
Net fx Rs m2,00015,669 12.8%   
CASH FLOW
From Operations Rs m15,4292,048 753.4%  
From Investments Rs m-3,27013,062 -25.0%  
From Financial Activity Rs m-10,504-17,094 61.4%  
Net Cashflow Rs m2,254-1,837 -122.7%  

Share Holding

Indian Promoters % 46.5 29.4 158.5%  
Foreign collaborators % 4.2 0.3 1,540.7%  
Indian inst/Mut Fund % 26.6 40.4 65.7%  
FIIs % 24.8 25.8 96.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 49.3 70.4 70.1%  
Shareholders   87,493 96,976 90.2%  
Pledged promoter(s) holding % 0.0 26.3 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare JUBILANT PHARMOVA With:   ADVANCED ENZYME TECHNOLOGIES  UNJHA FORMUL  GENNEX LAB.  AVON ORGANIC  TTK HEALTHCARE  



Today's Market

5 Reasons Why Sensex Ended 873 Points Higher Today(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended on a strong note.

Related Views on News

STRIDES PHARMA SCIENCE Announces Quarterly Results (3QFY21); Net Profit Down 46.4% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, STRIDES PHARMA SCIENCE has posted a net profit of Rs 621 m (down 46.4% YoY). Sales on the other hand came in at Rs 8 bn (up 13.6% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.

STRIDES PHARMA SCIENCE Announces Quarterly Results (1QFY21); Net Profit Up 184.5% (Quarterly Result Update)

Aug 20, 2020 | Updated on Aug 20, 2020

For the quarter ended June 2020, STRIDES PHARMA SCIENCE has posted a net profit of Rs 1 bn (up 184.5% YoY). Sales on the other hand came in at Rs 8 bn (up 14.0% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (4QFY20); Net Profit Up 358.8% (Quarterly Result Update)

Jun 1, 2020 | Updated on Jun 1, 2020

For the quarter ended March 2020, JUBILANT LIFE SCIENCES has posted a net profit of Rs 3 bn (up 358.8% YoY). Sales on the other hand came in at Rs 24 bn (up 0.2% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (3QFY20); Net Profit Down 24.0% (Quarterly Result Update)

Feb 1, 2020 | Updated on Feb 1, 2020

For the quarter ended December 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (down 24.0% YoY). Sales on the other hand came in at Rs 23 bn (down 2.6% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

STRIDES PHARMA SCIENCE Announces Quarterly Results (2QFY20); Net Profit Up 2778.7% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, STRIDES PHARMA SCIENCE has posted a net profit of Rs 2 bn (up 2778.7% YoY). Sales on the other hand came in at Rs 7 bn (down 2.4% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.

More Views on News

Most Popular

Make Startup Profits from Bluechip Stocks(Profit Hunter)

Jul 21, 2021

A 166-bagger stock can deliver even more gains in this decade.

These Are the Best Stocks to Own(Fast Profits Daily)

Jul 22, 2021

Find out what I think are the best kind on stocks to own in the market.

Cash the Crash in Gas Prices(Fast Profits Daily)

Jul 21, 2021

Get ready to profit from the coming crash in the price of natural gas.

A Trading Hack to Multiply Profits(Fast Profits Daily)

Jul 23, 2021

Use this trading hack and get a big boost in your trading profits.

How to Pick Momentum Stocks(Fast Profits Daily)

Jul 26, 2021

Use my trading momentum strategy to increase your trading profits.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT PHARMOVA SHARE PRICE


Aug 3, 2021 (Close)

TRACK JUBILANT PHARMOVA

  • Track your investment in JUBILANT PHARMOVA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT PHARMOVA

JUBILANT PHARMOVA 8-QTR ANALYSIS

COMPARE JUBILANT PHARMOVA WITH

MARKET STATS